Autolus Therapeutics Plc (AUTL)
2.345
-0.06
(-2.70%)
USD |
NASDAQ |
Aug 24, 16:00
2.34
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Shareholders Equity (Quarterly) : 74.84M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 74.84M |
| March 31, 2026 | 108.83M |
| December 31, 2025 | 178.13M |
| September 30, 2025 | 265.45M |
| June 30, 2025 | 346.46M |
| March 31, 2025 | 371.11M |
| December 31, 2024 | 427.32M |
| September 30, 2024 | 476.96M |
| June 30, 2024 | 527.84M |
| March 31, 2024 | 582.03M |
| December 31, 2023 | 111.47M |
| September 30, 2023 | 180.52M |
| June 30, 2023 | 229.34M |
| March 31, 2023 | 266.92M |
| December 31, 2022 | 298.67M |
| Date | Value |
|---|---|
| September 30, 2022 | 161.15M |
| June 30, 2022 | 214.52M |
| March 31, 2022 | 271.14M |
| December 31, 2021 | 313.32M |
| September 30, 2021 | 244.73M |
| June 30, 2021 | 283.68M |
| March 31, 2021 | 299.57M |
| December 31, 2020 | 210.03M |
| September 30, 2020 | 236.81M |
| June 30, 2020 | 258.95M |
| March 31, 2020 | 287.48M |
| December 31, 2019 | 254.84M |
| September 30, 2019 | 269.64M |
| June 30, 2019 | 298.22M |
| March 31, 2019 | 217.88M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | 510.26M |
| Biodexa Pharmaceuticals Plc | -- |
| argenx SE | -- |
| Mereo BioPharma Group Plc | 28.65M |
| Evaxion AS | 9.531M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 493.23M |
| Total Liabilities (Quarterly) | 418.39M |
| Debt to Equity Ratio | 4.915 |
| Current Ratio | 4.847 |
| Net Debt Paydown Yield | -2.66% |